Correction to: Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells

Cell Mol Neurobiol. 2018 Oct;38(7):1451. doi: 10.1007/s10571-018-0604-7.

Abstract

The original version of this article unfortunately contained a mistake in the unit of agmatine doses. The agmatine doses were erroneously written in nanomolar in the published article. The correct effective doses of agmatine were 150 and 250 µM.

Publication types

  • Published Erratum